CRIS Q1 2017 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+23.5% YoY

Gross Profit

$2M94.8% margin

Operating Income

-$15M-706.4% margin

Net Income

-$16M-738.7% margin

EPS (Diluted)

$-11.09

QoQ Revenue Growth

-9.8%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$74M

Total Liabilities

$52M

Stockholders' Equity

$21M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+23.5%
Gross Profit	$2M	$2M	+23.4%
Operating Income	-$15M	-$9M	-70.9%
Net Income	-$16M	-$9M	-66.7%

Revenue Segments

Drug Development Royalty

$100,000100%